首页> 美国卫生研究院文献>Insights into Imaging >Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview
【2h】

Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview

机译:g神经造影剂中基于lin的造影剂的替代技术的诊断价值-全面概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Gadolinium-based contrast agents (GBCAs) increase lesion detection and improve disease characterization for many cerebral pathologies investigated with MRI. These agents, introduced in the late 1980s, are in wide use today. However, some non-ionic linear GBCAs have been associated with the development of nephrogenic systemic fibrosis in patients with kidney failure. Gadolinium deposition has also been found in deep brain structures, although it is of unclear clinical relevance. Hence, new guidelines from the International Society for Magnetic Resonance in Medicine advocate cautious use of GBCA in clinical and research practice. Some linear GBCAs were restricted from use by the European Medicines Agency (EMA) in 2017.This review focuses on non-contrast-enhanced MRI techniques that can serve as alternatives for the use of GBCAs. Clinical studies on the diagnostic performance of non-contrast-enhanced as well as contrast-enhanced MRI methods, both well established and newly proposed, were included. Advantages and disadvantages together with the diagnostic performance of each method are detailed. Non-contrast-enhanced MRIs discussed in this review are arterial spin labeling (ASL), time of flight (TOF), phase contrast (PC), diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS), susceptibility weighted imaging (SWI), and amide proton transfer (APT) imaging.Ten common diseases were identified for which studies reported comparisons of non-contrast-enhanced and contrast-enhanced MRI. These specific diseases include primary brain tumors, metastases, abscess, multiple sclerosis, and vascular conditions such as aneurysm, arteriovenous malformation, arteriovenous fistula, intracranial carotid artery occlusive disease, hemorrhagic, and ischemic stroke.In general, non-contrast-enhanced techniques showed comparable diagnostic performance to contrast-enhanced MRI for specific diagnostic questions. However, some diagnoses still require contrast-enhanced imaging for a complete examination.
机译:基于d的造影剂(GBCA)可提高病变的检出率,并改善通过MRI研究的许多脑病理学的疾病特征。这些试剂于1980年代后期推出,如今已广泛使用。但是,一些非离子型线性GBCA与肾衰竭患者肾源性系统性纤维化的发展有关。 deep沉积物也已在脑深部结构中发现,尽管尚无临床相关性。因此,国际磁共振医学协会的新指南主张在临床和研究实践中谨慎使用GBCA。 2017年,欧洲药品管理局(EMA)限制了某些线性GBCA的使用。本综述着重于非造影增强MRI技术,这些技术可以替代GBCA的使用。既有完善的又有新提议的非增强和对比增强MRI方法的诊断性能的临床研究。详细介绍了每种方法的优缺点以及诊断性能。本文中讨论的非增强MRI包括动脉自旋标记(ASL),飞行时间(TOF),相衬(PC),扩散加权成像(DWI),磁共振波谱(MRS),磁化率加权成像( SWI)和酰胺质子转移(APT)成像。确定了十种常见疾病,这些研究报告了无对比增强MRI和对比增强MRI的比较。这些特定疾病包括原发性脑部肿瘤,转移瘤,脓肿,多发性硬化症和血管疾病,例如动脉瘤,动静脉畸形,动静脉瘘,颅内颈动脉闭塞性疾病,出血和缺血性中风。在特定的诊断问题上与造影剂MRI具有可比的诊断性能。但是,某些诊断仍需要对比增强成像才能进行完整检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号